Skip to main content

Advertisement

SpringerLink
Log in

Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

To assess the prevalence and predictive value of natural autoantibodies to high-mobility group box 1 (HMGB1) during sepsis.

Methods

Anti-HMGB1 and anti-human serum albumin (HSA) autoantibodies were detected by ELISA in 178 plasma samples longitudinally collected from 40 critically ill patients with septic shock. One hundred thirty-two plasma samples from healthy donors were used as control.

Results

IgGs to HMGB1 were detected in 15/40 patients (37.5%). The prevalence of anti-HMGB1 antibodies was significantly higher in the patients who survived (55%) compared to the patients who did not (20%) (p < 0.0001). The detection of anti-HMGB1 antibodies during the course of the disease was significantly associated with patient survival (p = 0.038). Moreover, there is a progressive and significant emergence of anti-HMGB1 antibodies during the course of the disease, mostly in patients who survived.

Conclusions

This study shows that autoantibodies to HMGB1 are produced during sepsis and are associated with a favorable outcome in patients undergoing septic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stros M (2010) HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 1799:101–113

    PubMed  CAS  Google Scholar 

  2. Yang H, Tracey KJ (2009) Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799:149–156

    PubMed  Google Scholar 

  3. Bianchi ME (2009) HMGB1 loves company. J Leuk Biol 86:573–576

    Article  CAS  Google Scholar 

  4. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195

    Article  PubMed  CAS  Google Scholar 

  5. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, Thorburn A (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 16:175–183

    Article  PubMed  CAS  Google Scholar 

  6. Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS (2006) The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291:C1318–C1325

    Article  PubMed  CAS  Google Scholar 

  7. Rauvala H, Rouhiainen A (2010) Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta 1799:164–170

    PubMed  CAS  Google Scholar 

  8. Tsung A, Klune JR, Zhang X, Jeyabian G, Cao Z, Peng X, Stolz Geller DA, Rosengart MR, Billiar TR (2007) HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204:2913–2923

    Article  PubMed  CAS  Google Scholar 

  9. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H (2006) HMGB1 signals through toll-like recpetor (TLR) 4 and TLR2. Shock 26:174–179

    Article  PubMed  CAS  Google Scholar 

  10. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251

    Article  PubMed  CAS  Google Scholar 

  11. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, Soejima J, Koh H, Ishizaka A (2004) Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170:1310–1316

    Article  PubMed  Google Scholar 

  12. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33:564–573

    Article  PubMed  CAS  Google Scholar 

  13. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE (2007) High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33:1347–1353

    Article  PubMed  CAS  Google Scholar 

  14. Watanabe M, Uchida K, Nakagaki K, Kanazawa H, Trapnell BC, Hoshino Y, Kagamu H, Yoshizawa H, Keicho N, Goto H, Nakata K (2007) Anti-cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett 581:2017–2021

    Article  PubMed  CAS  Google Scholar 

  15. Bakhiet M, Diab A, Mahamustafa Jiezhu, Lindqvist L, Link H (1997) Potential role of autoantibodies in the regulation of cytokine responses during bacterial infections. Infect Immun 65:3300–3303

    PubMed  CAS  Google Scholar 

  16. Thierry S, Gozlan J, Jaulmes A, Boniface R, Nasreddine N, Strauss F, Marechal V (2007) High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS 21:283–292

    Article  PubMed  CAS  Google Scholar 

  17. Avrameas S, Guilbert B, Dighiero G (1981) Natural antibodies against tubulin, actin myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera, and monoclonal immunoglobulins from multiple myeloma and Waldenström’s macroglobulinemia may express similar antibody specificities. Ann Immunol (Paris) 132C:231–236

    CAS  Google Scholar 

  18. Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L (2007) Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 35:1061–1067

    Article  PubMed  Google Scholar 

  19. Karlsson S, Pettila V, Tenhunen J, Laru-Sompa R, Hynninen M, Ruokonen E (2008) HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 34:1046–1053

    Article  PubMed  CAS  Google Scholar 

  20. Fomsgaard A, Zhang GH, Shand GH, Bendtzen K, Baek L (1989) Immunochemical and biological reactivity of human anti-lipopolysaccharide IgG obtained by screening of blood donors. Scand J Immunol 29:309–316

    Article  PubMed  CAS  Google Scholar 

  21. Lacroix-Desmazes S, Bayry J, Kaveri SV, Hayon-Sonsino D, Thorenoor N, Charpentier J, Luyt CE, Mira JP, Nagaraja V, Kazatchkine MD, Dhainaut JF, Mallet VO (2005) High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci USA 102:4109–4113

    Article  PubMed  CAS  Google Scholar 

  22. Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE (2007) Factors masking HMGB1 in human serum and plasma. J Leuk Biol 81:67–74

    Article  CAS  Google Scholar 

Download references

Acknowlegdments

CB received a PhD fellowship from the Ministère de l’Enseignement Supérieur et de la Recherche français, from the Réseau Herpesvirus et Cancer and from La Ligue contre le Cancer. SBV is indebted to Mélanie Messmer for her helpful discussions and constant support. The authors are grateful to Dr. Joel Gozlan for comments and fruitful discussions.

Conflict of interest

All authors certify that there is no conflict of interest.

Author information

Author notes

  1. Stéphanie Barnay-Verdier

    Present address: , UMR 7138 UPMC-CNRS-UNS, Equipe Symbiose Marine, Nice, 06108, France

Authors and Affiliations

  1. Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, UMRS 872, escalier F 2ème étage, 15 rue de l’école de médecine, Paris, 75006, France

    Stéphanie Barnay-Verdier, Lakhdar Fattoum, Chloé Borde, Srini Kaveri & Vincent Maréchal

  2. Université Paris Descartes, UMRS 872, Paris, 75006, France

    Stéphanie Barnay-Verdier, Lakhdar Fattoum, Chloé Borde, Srini Kaveri & Vincent Maréchal

  3. INSERM, U872, Paris, 75006, France

    Stéphanie Barnay-Verdier, Lakhdar Fattoum, Chloé Borde, Srini Kaveri & Vincent Maréchal

  4. Hôpital Central, Service de Réanimation Médicale, 29 avenue du Maréchal de Lattre de Tassigny, Nancy, 54000, France

    Sébastien Gibot

Authors
  1. Stéphanie Barnay-Verdier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lakhdar Fattoum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chloé Borde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Srini Kaveri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sébastien Gibot
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vincent Maréchal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stéphanie Barnay-Verdier.

Additional information

V. Maréchal and S. Gibot share the seniorship position.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnay-Verdier, S., Fattoum, L., Borde, C. et al. Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock. Intensive Care Med 37, 957–962 (2011). https://doi.org/10.1007/s00134-011-2192-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-011-2192-6

Keywords

Search

Navigation